118 related articles for article (PubMed ID: 16149478)
1. [Growth hormone (GH, hGH)].
Fukuda I; Hizuka N
Nihon Rinsho; 2005 Aug; 63 Suppl 8():163-5. PubMed ID: 16149478
[No Abstract] [Full Text] [Related]
2. [Insulin-like growth factor (IGF)-I and IGF-II].
Okubo Y; Hizuka N
Nihon Rinsho; 2005 Aug; 63 Suppl 8():177-9. PubMed ID: 16149481
[No Abstract] [Full Text] [Related]
3. [Growth hormone-releasing hormone (GHRH)].
Katakami H
Nihon Rinsho; 2005 Aug; 63 Suppl 8():166-71. PubMed ID: 16149479
[No Abstract] [Full Text] [Related]
4. [Growth hormone-binding protein (GHBP)].
Katsumata N
Nihon Rinsho; 2005 Aug; 63 Suppl 8():183-5. PubMed ID: 16149483
[No Abstract] [Full Text] [Related]
5. Establishment of reference values for endocrine tests--part V: acromegaly.
Endert E; van Rooden M; Fliers E; Prummel MF; Wiersinga WM
Neth J Med; 2006; 64(7):230-5. PubMed ID: 16929084
[TBL] [Abstract][Full Text] [Related]
6. [Delayed growth with raised circulating growth hormone and incapacity to produce somatomedin (dwarfism of Laron type)].
Rappaport R; Czernichow P; Prevost C; Jullien M
Ann Pediatr (Paris); 1977 Jan; 24(1):63-7. PubMed ID: 16211946
[No Abstract] [Full Text] [Related]
7. Current diagnostic guidelines for biochemical diagnosis of acromegaly.
Ferone D; Resmini E; Bocca L; Giusti M; Barreca A; Minuto F
Minerva Endocrinol; 2004 Dec; 29(4):207-23. PubMed ID: 15765030
[TBL] [Abstract][Full Text] [Related]
8. [Growth hormone (GH, hGH)].
Ishikawa M; Inoue K
Nihon Rinsho; 1999 Dec; 57 Suppl():5-7. PubMed ID: 10778047
[No Abstract] [Full Text] [Related]
9. Natural history of the classical form of primary growth hormone (GH) resistance (Laron syndrome).
Laron Z
J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():231-49. PubMed ID: 10698588
[TBL] [Abstract][Full Text] [Related]
10. Biochemical markers of acromegaly: GH vs. IGF-I.
Barkan AL
Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S97-100. PubMed ID: 15135787
[TBL] [Abstract][Full Text] [Related]
11. [Growth hormone (GH, hGH)].
Fukuda I; Hizuka N
Nihon Rinsho; 2010 Jul; 68 Suppl 7():189-91. PubMed ID: 20963864
[No Abstract] [Full Text] [Related]
12. Growth hormone isoforms in acromegalic patients before and after treatment with octreotide LAR.
Lima GA; Wu Z; Silva CM; Barbosa FR; Dias JS; Schrank Y; Strasburger CJ; Gadelha MR
Growth Horm IGF Res; 2010 Apr; 20(2):87-92. PubMed ID: 19884028
[TBL] [Abstract][Full Text] [Related]
13. [Plasma growth hormone-releasing hormone assay and the clinical significance].
Saito H; Saito S
Nihon Rinsho; 1990 Feb; 48 Suppl():157-62. PubMed ID: 2113116
[No Abstract] [Full Text] [Related]
14. [Follicle stimulating hormone (FSH)].
Sawada K; Tasaka K
Nihon Rinsho; 2005 Aug; 63 Suppl 8():193-5. PubMed ID: 16149486
[No Abstract] [Full Text] [Related]
15. [Recent progress in diagnosis and treatment of patients with GH deficiency and GH overproduction].
Takano K
Nihon Rinsho; 1993 Oct; 51(10):2679-84. PubMed ID: 8254939
[TBL] [Abstract][Full Text] [Related]
16. [Luteinizing hormone].
Sakata M; Hayashi M; Tahara M
Nihon Rinsho; 2005 Aug; 63 Suppl 8():190-2. PubMed ID: 16149485
[No Abstract] [Full Text] [Related]
17. Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly.
Sartorio A; Cattaneo M; Bucciarelli P; Bottasso B; Porretti S; Epaminonda P; Faglia G; Arosio M
Exp Clin Endocrinol Diabetes; 2000; 108(7):486-92. PubMed ID: 11083070
[TBL] [Abstract][Full Text] [Related]
18. [Neurotensin].
Kimura K; Shimosegawa T
Nihon Rinsho; 2005 Aug; 63 Suppl 8():244-7. PubMed ID: 16149501
[No Abstract] [Full Text] [Related]
19. [Growth hormone].
Gava R; Plebani M; Beltrami GC; Grezzana L
G Clin Med; 1990 Apr; 71(4):289-91, 294-6. PubMed ID: 2115015
[No Abstract] [Full Text] [Related]
20. Discordant nadir GH after oral glucose and IGF-I levels on treated acromegaly: refining the biochemical markers of mild disease activity.
Elias PC; Lugao HB; Pereira MC; Machado HR; Castro Md; Moreira AC
Horm Metab Res; 2010 Jan; 42(1):50-5. PubMed ID: 19798623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
